Author Correction: Major lung complications of systemic sclerosis

Article metrics

  • 475 Accesses

Nature Reviews Rheumatology (2018) https://doi.org/10.1038/s41584-018-0062-0 Published online 15 August 2018

In the originally published version of this article, Table 2 contained an error. In this table, the statement “Also licensed for CTEPH; cannot be combined with a PDE5 inhibitor” was in the wrong row and incorrectly attributed to the drug selexipag, whereas this statement was actually referring to the drug riociguat. Furthermore, the reference supporting this statement was incorrect. These errors have now been corrected in the HTML and PDF versions of the manuscript.

Author information

Correspondence to Christopher P. Denton.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Denton, C.P., Wells, A.U. & Coghlan, J.G. Author Correction: Major lung complications of systemic sclerosis. Nat Rev Rheumatol 14, 682 (2018) doi:10.1038/s41584-018-0108-3

Download citation